Aclima Pharmaceuticals Pvt. Ltd. - Company Profile

It is a chemicals private limited company based in Kolkata, West Bengal, India, established in 1993.
1993 Kolkata, West Bengal, India Struck Off
Last Updated:
About Aclima Pharmaceuticals Pvt. Ltd.

Aclima Pharmaceuticals Pvt. Ltd., a struck off private limited company, was established on 12 October 1993 in Kolkata, West Bengal, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233WB1993PTC060417. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹40.00 K .

Its leadership includes Samir Banerjee (Director), Namita Banerjee (Director). It holds no open charges and ₹0.28 M settled loans. It is based at 373/2 Block G New Alipur, Kolkata, West Bengal.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233WB1993PTC060417

  • Registration Number

    060417

  • Incorporation Date

    12 October 1993

  • Authorized Capital

    ₹6.00 M

  • Paid-Up Capital

    ₹40.00 K

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 6.00 M
  • Paid Up Capital ₹ 40.00 K
  • Company Age 32 Year, 6 Months
  • Satisfied Charges ₹ 0.28 M
Company report

Aclima Pharmaceuticals Pvt. Ltd.

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Aclima Pharmaceuticals Pvt. Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aclima Pharmaceuticals Pvt. Ltd.?
Current Directors
Name Designation Appointment Date Status
Samir Banerjee Director 12 Oct 1993 Current
Namita Banerjee Director 12 Oct 1993 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aclima Pharmaceuticals.

Enhance accessibility to Aclima Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aclima Pharmaceuticals revenue growth over time
Aclima Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aclima Pharmaceuticals?

Unlock access to Aclima Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹281,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.03 Cr
Latest Charge Details
Date Lender Amount Status
15 Nov 1995 State Bank Of India ₹0.28 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aclima Pharmaceuticals?

Unlock and access historical data on people associated with Aclima Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aclima Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aclima Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aclima Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge registered on 15 Nov 1995 via Charge ID 80048226 with State Bank Of India was fully satisfied on 27 Aug 2008. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 0.28 M with Charge ID 80048226 was registered on 15 Nov 1995. was documented.

  • Director Appointment

    Progress on Samir Banerjee was appointed as a Director was appointed as a Director on 12 Oct 1993 & has been associated with this company since 32 years 6 months . was documented.

  • Director Appointment

    Progress on Namita Banerjee was appointed as a Director was appointed as a Director on 12 Oct 1993 & has been associated with this company since 32 years 6 months . was documented.

  • Company Incorporation

    Aclima Pharmaceuticals Pvt. Ltd. was registered on 12 Oct 1993 with Roc Kolkata & aged 32 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aclima Pharmaceuticals Pvt. Ltd.?

The CIN of Aclima Pharmaceuticals Pvt. Ltd. is U24233WB1993PTC060417.

Where is Aclima Pharmaceuticals Pvt. Ltd. headquartered?

Aclima Pharmaceuticals Pvt. Ltd. is headquartered at 373/2 Block G New Alipur, Kolkata, West Bengal.

When was Aclima Pharmaceuticals Pvt. Ltd. incorporated?

Aclima Pharmaceuticals Pvt. Ltd. was incorporated on 12 October 1993.

Who are the current directors of Aclima Pharmaceuticals Pvt. Ltd.?

The current directors of Aclima Pharmaceuticals Pvt. Ltd. are

What is the primary industry of Aclima Pharmaceuticals Pvt. Ltd.?

The primary industry of Aclima Pharmaceuticals Pvt. Ltd. is Chemicals.

Is Aclima Pharmaceuticals Pvt. Ltd. a listed company?

Aclima Pharmaceuticals Pvt. Ltd. is unlisted.

What is the capital structure of Aclima Pharmaceuticals Pvt. Ltd.?

The authorized capital of Aclima Pharmaceuticals Pvt. Ltd. is ₹6.00 M, and the paid-up capital is ₹40.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available